人工血管の世界市場 - 市場考察、競合情勢、市場予測（2030年）

世界の人工血管の市場規模は、2023年に21億9,000万米ドルであり、2030年までに30億7,000万米ドルに達すると予測され、2024年～2030年の予測期間にCAGRで5.02％の成長が見込まれます。人工血管の需要は主に、老年人口の急速な増加と、さまざまな心血管疾患の有病率の上昇によって後押しされています。さらに、市場は技術の進歩、この分野で進行中の多数の研究活動、医療提供者、研究者、業界企業間の提携、戦略的パートナーシップなどの理由で成長すると予測され、これらが2024年～2030年の予測期間に市場の全体的な成長に寄与します。

人工血管の市場力学

心血管疾患は世界中で非常に流行しており、中でも冠動脈疾患と末梢血管疾患がもっとも大きな割合を占めています。例えば、米国心臓協会（American Heart Association）（2022）によると、2020年に全世界で約2億4,410万人が冠動脈（虚血）性心疾患を患っています。同資料によると、北アフリカ、中東、中央アジア、南アジア、東欧は、2020年の冠動脈性（虚血性）心疾患の有病率が世界でもっとも高いです。

英国心臓財団（British Heart Foundation）2022年のデータによると、2019年に全世界で約5億5,000万人（14人に1人）が心臓および循環器の疾患を患っており、これには約2億9,000万人の女性と約2億6,000万人の男性が含まれます。同じ資料によると、2019年、北米では、410万3,135人が心血管疾患に罹患し、108万9,947人が冠動脈疾患と診断され、49万8,551人が脳卒中に罹患し、アジアでは、3,237万6,834人が心血管疾患と診断され、そのうち1,254万3,833人が冠動脈疾患に罹患し、811万1,044人が脳卒中に罹患しました。

上記の資料はさらに、冠動脈（虚血性）心疾患、末梢動脈（血管）疾患、脳卒中、心房細動が2019年においても世界でもっとも一般的で有病率の高い心血管疾患であると述べています。

血管の狭窄、閉塞、または重度の機能不全は、心血管疾患のさまざまな病態生理学的メカニズムの1つです。大動脈は、特に腹部大動脈瘤、大動脈梗塞、慢性血液透析アクセスなどのさまざまな病状によって影響を受ける傾向があります。

閉塞した血管構造の治療には、人工血管の使用を伴う人工血管置換術が好ましい手術オプションです。人工血管の需要も、術後合併症の罹患率だけでなく、健康な自己血管の利用可能性が限られているために増加傾向にあります。

同様に、新型人工血管の開発に関する継続的な研究活動が、当面の市場成長を加速させる見込みです。例えば2022年9月、南デンマーク大学（SDU）とオーデンセ大学病院（OUH）の研究者が、閉塞や感染を防ぐ画期的な人工血管の開発に取り組んでいます。

しかし、人工血管の製造や開発の際に直面する課題と、人工血管に関連する規制遵守やその他の安全性に関する懸念が、人工血管市場全体の成長を抑制する可能性があります。

人工血管市場のセグメント分析

人工血管市場の用途セグメントでは、末梢動脈疾患カテゴリが2023年に大きな収益シェアを獲得すると予測されています。これは、末梢動脈疾患の有病率の上昇によるものと考えられます。

例えば、カナダ統計局の最新調査によると、PADは国内で広く流行しており、毎年約80万人のカナダ人が罹患しています。

また、末梢動脈疾患に関連する高齢、喫煙、高血圧などの危険因子の増加が、人工血管の市場成長をさらに後押ししています。

Canadian Census 2021によると、2021年に85歳以上の人口が86万1,000人を超えました。前述の資料はまた、2016年～2021年に、85歳以上の人口は12％増加し、これはカナダ全体の人口の増加の2倍以上であると述べています。

当レポートでは、世界の人工血管市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 人工血管市場レポートのイントロダクション

第2章 人工血管市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 人工血管市場の主な要因の分析

• 人工血管市場の促進要因
• 人工血管市場の抑制要因と課題
• 人工血管市場の機会

第6章 人工血管市場のポーターのファイブフォース分析

第7章 人工血管市場情勢

• ポリマータイプ別
  • ポリジオキサノン
  • エラストマー
  • ポリエチレンテレフタレート
  • その他
• 用途別
  • 大動脈疾患
  • 末梢動脈疾患
  • 血液透析
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 人工血管市場の企業と製品のプロファイル

• B. Braun SE
• Terumo Medical Corporation
• Roumai Med
• Jiangsu Bioda Life Science Co. Ltd
• W. L. Gore & Associates, Inc.
• LeMaitre Vascular Inc.
• Artivion, Inc
• Getinge
• Vygon

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Artificial Blood Vessels Market in Global (2021-2030)
• Table 3: Artificial Blood Vessels Market in Global by Polymer Type (2021-2030)
• Table 4: Artificial Blood Vessels Market in Global by Application (2021-2030)
• Table 5: Artificial Blood Vessels Market in Global by Geography (2021-2030)
• Table 6: Artificial Blood Vessels Market in North America (2021-2030)
• Table 7: Artificial Blood Vessels Market in the US (2021-2030)
• Table 8: Artificial Blood Vessels Market in Canada (2021-2030)
• Table 9: Artificial Blood Vessels Market in Mexico (2021-2030)
• Table 10: Artificial Blood Vessels Market in Europe (2021-2030)
• Table 11: Artificial Blood Vessels Market in France (2021-2030)
• Table 12: Artificial Blood Vessels Market in Germany (2021-2030)
• Table 13: Artificial Blood Vessels Market in the United Kingdom (2021-2030)
• Table 14: Artificial Blood Vessels Market in Italy (2021-2030)
• Table 15: Artificial Blood Vessels Market in Spain (2021-2030)
• Table 16: Artificial Blood Vessels Market in the Rest of Europe (2021-2030)
• Table 17: Artificial Blood Vessels Market in Asia-Pacific (2021-2030)
• Table 18: Artificial Blood Vessels Market in China (2021-2030)
• Table 19: Artificial Blood Vessels Market in Japan (2021-2030)
• Table 20: Artificial Blood Vessels Market in India (2021-2030)
• Table 21: Artificial Blood Vessels Market in Australia (2021-2030)
• Table 22: Artificial Blood Vessels Market in South Korea (2021-2030)
• Table 23: Artificial Blood Vessels Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Artificial Blood Vessels Market in the Rest of the World (2021-2030)
• Table 25: Artificial Blood Vessels Market in the Middle East (2021-2030)
• Table 26: Artificial Blood Vessels Market in Africa (2021-2030)
• Table 27: Artificial Blood Vessels Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Artificial Blood Vessels Market in Global (2021-2030)
• Figure 3: Artificial Blood Vessels Market in Global by Polymer Type (2021-2030)
• Figure 4: Artificial Blood Vessels Market in Global by Application (2021-2030)
• Figure 5: Artificial Blood Vessels Market in Global by Geography (2021-2030)
• Figure 6: Artificial Blood Vessels Market in North America (2021-2030)
• Figure 7: Artificial Blood Vessels Market in the US (2021-2030)
• Figure 8: Artificial Blood Vessels Market in Canada (2021-2030)
• Figure 9: Artificial Blood Vessels Market in Mexico (2021-2030)
• Figure 10: Artificial Blood Vessels Market in Europe (2021-2030)
• Figure 11: Artificial Blood Vessels Market in France (2021-2030)
• Figure 12: Artificial Blood Vessels Market in Germany (2021-2030)
• Figure 13: Artificial Blood Vessels Market in the United Kingdom (2021-2030)
• Figure 14: Artificial Blood Vessels Market in Italy (2021-2030)
• Figure 15: Artificial Blood Vessels Market in Spain (2021-2030)
• Figure 16: Artificial Blood Vessels Market in the Rest of Europe (2021-2030)
• Figure 17: Artificial Blood Vessels Market in Asia-Pacific (2021-2030)
• Figure 18: Artificial Blood Vessels Market in China (2021-2030)
• Figure 19: Artificial Blood Vessels Market in Japan (2021-2030)
• Figure 20: Artificial Blood Vessels Market in India (2021-2030)
• Figure 21: Artificial Blood Vessels Market in Australia (2021-2030)
• Figure 22: Artificial Blood Vessels Market in South Korea (2021-2030)
• Figure 23: Artificial Blood Vessels Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Artificial Blood Vessels Market in the Rest of the World (2021-2030)
• Figure 25: Artificial Blood Vessels Market in the Middle East (2021-2030)
• Figure 26: Artificial Blood Vessels Market in Africa (2021-2030)
• Figure 27: Artificial Blood Vessels Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Marker Opportunities
• Figure 31: PORTER'S Five Force Analysis

Artificial Blood Vessels Market By Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, And Others), Application (Aortic Disease, Peripheral Artery Disease, And Hemodialysis), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the prevalence of cardiovascular diseases (CVDS) and increasing research and development activities

The global artificial blood vessels market was valued at USD 2.19 billion in 2023, growing at a CAGR of 5.02% during the forecast period from 2024 to 2030 to reach USD 3.07 billion by 2030. The demand for artificial blood vessels is primarily being boosted by the rising prevalence of various cardiovascular diseases coupled with a rapidly growing geriatric population. Furthermore, the artificial blood vessels market is anticipated to grow on account of the growing technological advancement, a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute in the overall growth of the artificial blood vessels market during the forecast period from 2024-2030.

Artificial Blood Vessels Market Dynamics:

Cardiovascular diseases are highly prevalent across the globe, of which the largest proportion is taken by coronary and peripheral vascular diseases. For instance, according to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020. As per the same source, North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of coronary (ischemic) heart disease in the world in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men. As per the same source, in 2019, in North America, cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 suffered from stroke; In Asia, there were 32,376,834 people diagnosed with cardiovascular diseases, from which 12,543,833 individuals were affected by coronary artery disease, and 8,111,044 population was suffered from a stroke.

The source mentioned above further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the commonest and prevalent cardiovascular conditions worldwide in 2019.

Stenosis, occlusion, or severe dysfunction of blood vessels are among various pathophysiological mechanisms of cardiovascular diseases. The aorta tends to be affected by a range of disease conditions including abdominal aortic aneurysm, coarctation of the aorta, and chronic hemodialysis access among others.

For the treatment of obstructed vascular structures, vascular replacement involving the usage of artificial blood vessels is the preferred surgical option. The demand for artificial blood vessels is also on the rise due to the limited availability of healthy autologous vessels as well as the incidence of postoperative complications.

Similarly, ongoing research activities about the development of novel artificial blood vessels will accelerate market growth in the foreseeable future. For example, in September 2022, University of Southern Denmark (SDU) and Odense University Hospital (OUH) researchers are working on the development of a revolutionary artificial blood vessel that is prevented from closing or becoming infected.

However, regulatory compliance and other safety concerns associated with artificial blood vessels along with challenges encountered during manufacturing and development of artificial blood vessels may restrict the growth of the overall artificial blood vessels market.

Artificial Blood Vessels Market Segment Analysis:

Artificial Blood Vessels Market by Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, and Others), Application (Aortic Disease, Peripheral Artery Disease, and Hemodialysis), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the artificial blood vessels market, the peripheral artery disease category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the rising prevalence of peripheral artery disease.

For instance, as per the latest study provided by Statistic Canada, PAD is widely prevalent in the country, affecting approximately 800,000 Canadians, every year.

Also, the rise in the number of risk factors such as old age, smoking, hypertension, and others associated with peripheral artery disease is further boosting the market growth for artificial blood vessels.

As per the Canadian Census 2021, over 861,000 people aged 85 and older were counted in 2021. The aforesaid source also stated that, between 2016 and 2021, the number of people aged 85 and older grew by 12%, which is more than twice as high as the growth seen for the overall Canadian population.

According to the facts and figures provided by WHO in 2022, it was estimated that in Spain, almost every fifth of adults and adolescents smoke.

The same source stated that almost 18% of adults smoked tobacco in the year 2020 and 21% of adolescents aged 15-16 smoked cigarettes in 2019. The increasing consumption of tobacco and smoking among adults and youngsters will make them more prone to cardiovascular disorders such as PAD, and others.

By replacing the damaged native blood vessels, artificial blood vessels help to treat severe cases of peripheral artery disease.

Therefore, owing to the above-mentioned factors, the peripheral artery disease category is expected to register significant growth, thereby driving the growth of the overall artificial blood vessels market during the forecast period.

North America Is Expected To Dominate The Overall Artificial Blood Vessels Market:

Among all the regions, North America is estimated to account for the largest share of the Artificial Blood Vessels market in the year 2023. Owing to the significance of key growth factors such as the increased mortality rate due to aortic aneurysm, rise in cases of peripheral artery disease and coronary artery diseases among other cardiovascular disease conditions, growing awareness programs and initiatives related to heart health, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for artificial blood vessels is expected to witness prosperity in the region during the forecast period 2024-2030.

The Centers for Disease Control and Prevention (CDC) 2021 highlighted that aortic aneurysms or aortic dissections were responsible for causing about 9,904 deaths in 2019 in the United States. As per the same source, 59% of those deaths occurred among men. The number of deaths due to aortic aneurysms could have been avoided with proper surgical treatment via the utilization of artificial blood vessels.

As per the Centers for Disease Control and Prevention 2022, approximately 6.5 million people aged 40 and older were there with peripheral artery disease (PAD) condition in 2021 in the United States.

Another factor contributing to the growth of the artificial blood vessels market is the continued rise in the number of individuals involved in smoking. For instance, as per the Centers for Disease Control and Prevention 2022, approximately 40 million people smoke cigarettes in the US. As per the same source, every day nearly 1,600 US youth aged 18 years or younger smoke their first cigarette. Smoking increases the risk for a range of cardiovascular disease conditions.

Thus, the above-mentioned factors are likely to propel the growth of the artificial blood vessels market in the region during the forecast period from 2024-2030.

Artificial Blood Vessels Market Key Players:

Some of the key market players operating in the Artificial Blood Vessels market include LeMaitre Vascular Inc., Terumo Medical Corporation, W. L. Gore and Associates, B. Braun SE, Roumai Med, Jiangsu Bioda Life Science Co. Ltd., Artivion, Inc., Getinge, Vygon, and others.

Recent Developmental Activities In The Artificial Blood Vessels Market:

• In November 2022, Jiangsu Bioda Life Science Co. Ltd.'s artificial blood vessel gained class III medical device approval from China's NMPA, marking the first domestic artificial blood vessel to get such approval. Nantong, China-based Bioda's vessel is used for aortic coarctation and aneurysms.

Key Takeaways From The Artificial Blood Vessels Market Report Study

• Market size analysis for current artificial blood vessels market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global artificial blood vessels market.
• Various opportunities available for the other competitors in the artificial blood vessels market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current artificial blood vessels market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for artificial blood vessel market growth in the coming future?

Target Audience Who Can Be Benefited From This Artificial Blood Vessels Market Report Study

• Artificial Blood Vessels product providers
• Research organizations and consulting companies
• Artificial Blood Vessels -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in artificial blood vessels
• Various End-users who want to know more about the artificial blood vessels market and the latest technological developments in the artificial blood vessels market.

Frequently Asked Questions For The Artificial Blood Vessels Market:

1. What are artificial blood vessels?

Artificial blood vessels are represented as ideal vascular grafts that are composed of viable tissues. They offer advantages including compliance, lack of thrombogenicity, and resistance to infections among others.

2. What is the market for global artificial blood vessels?

The artificial blood vessels market was valued at USD 2.19 billion in 2023, growing at a CAGR of 5.02% during the forecast period from 2024 to 2030 to reach USD 3.07 billion by 2030.

3. What are the drivers for the global artificial blood vessels market?

The demand for artificial blood vessels is primarily being boosted by the increasing patient population suffering from various heart conditions benefits of artificial blood vessels for vascular obstruction, and continuous innovation in product development among others, thereby contributing to the overall growth of the Artificial Blood Vessels market during the forecast period from 2024-2030.

4. Who are the key players operating in the global artificial blood vessels market?

Some of the key market players operating in the artificial blood vessels market include LeMaitre Vascular Inc., Terumo Medical Corporation, W. L. Gore and Associates, B. Braun SE, Roumai Med, Jiangsu Bioda Life Science Co. Ltd., Artivion, Inc., Getinge, Vygon, and others.

5. Which region has the highest share in the artificial blood vessels market?

North America is expected to dominate the overall artificial blood vessels market during the forecast period from 2024-2030. Owing to factors such as the rise in the number of people with cardiovascular diseases, the surge in the number of awareness programs and initiatives for heart health, high disposable income, sophisticated healthcare infrastructure, and high awareness among others, North American artificial blood vessels market is expected to growth in coming years.

Table of Contents

1. Artificial Blood Vessels Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Artificial Blood Vessels Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Artificial Blood Vessels Market Key Factors Analysis

• 5.1. Artificial Blood Vessels Market Drivers
  • 5.1.1. The increasing prevalence of cardiovascular diseases (CVDs) coupled with the surge in risk factors such as old age, smoking, and others associated with causing CVDs
  • 5.1.2. Technological innovations in product development
  • 5.1.3. Collaboration between researchers, healthcare professionals, and industry players
• 5.2. Artificial Blood Vessels Market Restraints and Challenges
  • 5.2.1. Regulatory compliance and other safety concerns associated with artificial blood vessels
  • 5.2.2. Challenges encountered during manufacturing and development of artificial blood vessels
• 5.3. Artificial Blood Vessels Market Opportunities
  • 5.3.1. Surge in the number of research activities associated with the development of artificial blood vessels
  • 5.3.2. Advances in bioengineering techniques

6. Artificial Blood Vessels Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Artificial Blood Vessels Market Layout

• 7.1. By Polymer Type
  • 7.1.1. Polydioxanone
  • 7.1.2. Elastomer
  • 7.1.3. Polyethylene Terephthalate
  • 7.1.4. Others
• 7.2. By Application
  • 7.2.1. Aortic Disease
  • 7.2.2. Peripheral Artery Disease
  • 7.2.3. Hemodialysis
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.1.2. Canada Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.1.3. Mexico Artificial Blood Vessels Market Size in USD million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.2.2. Germany Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.2.3. United Kingdom Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.2.4. Italy Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.2.5. Spain Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.2.6. Rest of Europe Artificial Blood Vessels Market Size in USD million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.3.2. Japan Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.3.3. India Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.3.4. Australia Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.3.5. South Korea Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.3.6. Rest of Asia-Pacific Artificial Blood Vessels Market Size in USD million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.4.2. Africa Artificial Blood Vessels Market Size in USD million (2021-2030)
    • 7.3.4.3. South America Artificial Blood Vessels Market Size in USD million (2021-2030)

8. Artificial Blood Vessels Market Company and Product Profiles

• 8.1. B. Braun SE
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Terumo Medical Corporation
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Roumai Med
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Jiangsu Bioda Life Science Co. Ltd
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. W. L. Gore & Associates, Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. LeMaitre Vascular Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Artivion, Inc
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Getinge
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Vygon
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us